Retour
Fourchette du Jour
0,00 €
0,00 €
Fourchette 52 Semaines
0,00 €
0,00 €
Volume
14 706
Moyenne 50J / 200J
0,00 €
/
0,00 €
Clôture Précédente
0,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -143,7 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -128,3 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
Points Clés
Negative free cash flow of -894 320,0
PEG of 0,00 suggests growth is underpriced
Capital efficient — spends only 0,31% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)97,16%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net Margin-128,27%
Op. Margin-53,07%
Sécurité
Debt / Equity
N/A
Current Ratio0,31
Interest Coverage-4,34
Valorisation
P/E Ratio
-143,74
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 97,16% | Revenue Growth (3Y) | 62,45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,95M | Net Income (TTM) | -3,79M |
| ROE | N/A | ROA | -445,95% |
| Gross Margin | 25,05% | Operating Margin | -53,07% |
| Net Margin | -128,27% | Free Cash Flow (TTM) | -894 320,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,31 |
| Interest Coverage | -4,34 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -143,74 | P/B Ratio | N/A |
| P/S Ratio | 184,37 | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 544,73M | Enterprise Value | 545,56M |
Income Statement
Annual, most recent first
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | 2,95M | 1,50M | 1,12M | 1,08M | 0,0 |
| Net Income | -3,79M | -28,54M | -2,79M | -1,12M | -2,10M |
| EPS (Diluted) | -1,19 | -18,84 | -0,03 | -0,67 | -348,71 |
| Gross Profit | 740 181,0 | 273 944,0 | 263 180,0 | 252 036,0 | 0,0 |
| Operating Income | -1,57M | -27,24M | -2,73M | -1,00M | -1,33M |
Balance Sheet
Annual, most recent first
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Total Assets | 849 816,0 | 2,64M | 627 162,0 | 2,90M | 1,56M |
| Total Liabilities | 2,19M | 2,25M | 922 286,0 | 561 823,0 | 275 156,0 |
| Shareholders' Equity | -1,34M | 391 017,0 | -295 124,0 | 2,34M | 1,28M |
| Total Debt | 966 395,0 | 1,03M | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 131 696,0 | 231 700,0 | 68 546,0 | 88 233,0 | 683 795,0 |
| Current Assets | 615 060,0 | 511 183,0 | 364 245,0 | 2,61M | 794 312,0 |
| Current Liabilities | 2,02M | 1,29M | 922 286,0 | 561 823,0 | 275 156,0 |